Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01259037 · ClinicalTrials.gov registry record

A Study of Ultrasonography With Elastography in Skin Neoplasms

A clinical trial, sponsored by Wayne State University.

Completed
Registry status
30
Enrollment target

NCT01259037: Completed study, sponsored by Wayne State University.

NCT01259037 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01259037 has completed, sponsored by Wayne State University.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

This study will look at high frequency ultrasound as a medical imaging modality and apply it to skin lesions. Elastography is an ultrasonic method of looking at the hardness of an area. We will use this to try and differentiate between benign and cancerous skin lesions.

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2009-01
Est. Completion 2017-10-29
Wayne State University

163 total trials

What the finished NCT01259037 record still lists

NCT01259037 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01259037 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01259037 about?

NCT01259037 is a clinical study titled "A Study of Ultrasonography With Elastography in Skin Neoplasms". This study will look at high frequency ultrasound as a medical imaging modality and apply it to skin lesions. Elastography is an ultrasonic method of looking at the hardness of an area. We will use this to try and differentiate between benign and cancerous skin lesions.

What is the current status of trial NCT01259037?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-01. Estimated completion is 2017-10-29.

Who is sponsoring clinical trial NCT01259037?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01259037, the US trial registry maintained by the National Library of Medicine. NCT01259037 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.